Speaker illustration

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

P. Gabriel Steg, MD, FESC, FACC Born Feb 16, 1959 Université Paris-Cité, INSERM U-1148, Département de Cardiologie, Hôpital Bichat Assistance Publique - Hôpitaux de Paris 46, rue Henri Huchard, 75877 Paris cedex 18, France Phone: +33 1 40 25 86 68, Fax : +33 1 40 25 88 65 E-mail: gabriel.steg@aphp.fr Affiliations - Chief, Department of Cardiology, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, in Paris, France. - Vice President (in charge of research) of the board of Assistance Publique-Hôpitaux de Paris since 2018. - Professor of Cardiology at Université Paris - Cité (since 1994). - Senior Professor, Institut Universitaire de France (Innovation Chair) - Director of the “Clinical Research in Atherothrombosis” Research Team, INSERM Unit U1148, Paris - Coordinator of the iVASC (InnoVations in Atherothrombosis SCience) RHU research consortium. - Chair of the FACT (French Alliance for cardiovascular Clinical Trials) academic research network

Revascularisation dilemmas in chronic coronary syndromes

Event: ESC Congress 2023

Topic: Treatment

Session type: Symposium

Thumbnail

Fine-tuning post-acute coronary syndrome cardio protection: the case for early and aggressive lipid-lowering

Event: ESC Congress 2023

Topic: Lipid-Lowering Agents

Session type: Satellite Symposium

Thumbnail

HOT LINE SESSION 9

Event: ESC Congress 2022

Topic: European Society of Cardiology

Session type: Hot Line

Thumbnail

Lipid lowering and antiplatelet strategies post- acute coronary syndromes (ACS): a case-based discussion

Event: ESC Congress 2022

Topic: Acute Coronary Syndromes, Other

Session type: Satellite Symposium

Thumbnail

Late Breaking Trials in ACS

Event: ESC Congress 2021 - The Digital Experience

Topic: Acute Coronary Syndromes

Session type: Late-Breaking Science

Thumbnail

Clinical Update on Managing Hypertriglyceridaemia with Omega-3 Fatty Acid Icosapent Ethyl

Event: ESC Congress 2020

Topic: Cardiovascular Risk Assessment

Session type: Industry Q&A session

Thumbnail

Hot Line Session 6

Event: ESC Congress 2019

Topic: European Society of Cardiology, Other

Session type: Late-Breaking Science

Thumbnail

Confronting cardiovascular risk in patients with diabetes - Spotlight on dual antiplatelet therapy (EBAC Accredited)

Event: ESC Congress 2019

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Satellite Symposium

Thumbnail

Cardiovascular drugs in acute coronary syndromes: when to start and when to stop

Event: ESC Congress 2019

Topic: Pharmacology and Pharmacotherapy

Session type: Symposium

Thumbnail

Identifying patients who may benefit most from PCSK9i: highlights from the latest ODYSSEY OUTCOMES data

Event: ESC Congress 2018

Topic: Acute Coronary Syndromes

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb